Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Joseph Catanzaro is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/08/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 170.27% | $40 → $40 | Maintains | Overweight | Get Alert |
| 07/03/2024 | BDTX | Buy Now | Black Diamond Therapeutic | $4.37 | 174.6% | $12 → $12 | Maintains | Overweight | Get Alert |
| 06/14/2024 | OCUL | Buy Now | Ocular Therapeutix | $6.66 | 125.23% | $15 → $15 | Maintains | Overweight | Get Alert |
| 06/07/2024 | BMEA | Buy Now | Biomea Fusion | $4.80 | 108.33% | $45 → $10 | Maintains | Overweight | Get Alert |
| 06/07/2024 | HALO | Buy Now | Halozyme Therapeutics | $52.58 | -3% | $48 → $51 | Downgrade | Overweight → Neutral | Get Alert |
| 06/05/2024 | NRIX | Buy Now | Nurix Therapeutics | $20.61 | 69.82% | $35 → $35 | Maintains | Overweight | Get Alert |
| 05/28/2024 | CTMX | Buy Now | CytomX Therapeutics | $1.30 | 169.23% | $2.25 → $3.5 | Upgrade | Neutral → Overweight | Get Alert |
| 05/16/2024 | CNTX | Buy Now | Context Therapeutics | $1.73 | 160.12% | → $4.5 | Initiates | → Overweight | Get Alert |
| 04/29/2024 | IBRX | Buy Now | ImmunityBio | $6.64 | -9.62% | $5 → $6 | Maintains | Neutral | Get Alert |
| 04/25/2024 | ACRV | Buy Now | Acrivon Therapeutics | $7.08 | 323.73% | $26 → $30 | Maintains | Overweight | Get Alert |
| 04/22/2024 | BOLD | Buy Now | Boundless Bio | $4.47 | 347.43% | → $20 | Initiates | → Overweight | Get Alert |
| 04/05/2024 | ACHL | Buy Now | Achilles Therapeutics | $0.82 | 143.31% | $8 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 03/27/2024 | KROS | Buy Now | Keros Therapeutics | $41.68 | 151.92% | → $105 | Maintains | Overweight | Get Alert |
| 03/27/2024 | LENZ | Buy Now | LENZ Therapeutics | $18.38 | 52.34% | → $28 | Initiates | → Overweight | Get Alert |
| 03/26/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 170.27% | $40 → $40 | Maintains | Overweight | Get Alert |
| 03/25/2024 | IBRX | Buy Now | ImmunityBio | $6.64 | -24.68% | $4 → $5 | Maintains | Neutral | Get Alert |
| 03/18/2024 | IMAB | Buy Now | I-MAB | $1.60 | 525% | $15 → $10 | Maintains | Overweight | Get Alert |
| 03/14/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $7.32 | 159.56% | $18 → $19 | Maintains | Overweight | Get Alert |
| 03/11/2024 | RVMD | Buy Now | Revolution Medicines | $42.30 | 1.65% | → $43 | Initiates | → Overweight | Get Alert |
| 03/01/2024 | CRDF | Buy Now | Cardiff Oncology | $2.22 | 215.32% | $5 → $7 | Maintains | Overweight | Get Alert |
| 02/29/2024 | SDGR | Buy Now | Schrodinger | $21.19 | 135.96% | $60 → $50 | Maintains | Overweight | Get Alert |
| 02/28/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 170.27% | $45 → $40 | Maintains | Overweight | Get Alert |
| 02/26/2024 | OCUL | Buy Now | Ocular Therapeutix | $6.66 | 125.23% | $10 → $15 | Maintains | Overweight | Get Alert |
| 02/20/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $7.32 | 145.9% | $14 → $18 | Maintains | Overweight | Get Alert |
| 02/12/2024 | TNGX | Buy Now | Tango Therapeutics | $8.88 | 102.7% | → $18 | Initiates | → Overweight | Get Alert |
| 12/27/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $10 | Downgrade | Overweight → Neutral | Get Alert |
| 12/15/2023 | AADI | Buy Now | Aadi Bioscience | $1.37 | 264.96% | $30 → $5 | Maintains | Overweight | Get Alert |
| 12/04/2023 | IMGN | Buy Now | Immunogen | — | — | $24 → $31 | Downgrade | Overweight → Neutral | Get Alert |
| 10/16/2023 | RPTX | Buy Now | Repare Therapeutics | $3.21 | 678.82% | $30 → $25 | Maintains | Overweight | Get Alert |
| 10/10/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $58 | Downgrade | Overweight → Neutral | Get Alert |
| 08/15/2023 | TSBX | Buy Now | Turnstone Biologics | $2.26 | 784.96% | → $20 | Initiates | → Overweight | Get Alert |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $67.72 | 47.67% | $105 → $100 | Maintains | Overweight | Get Alert |
| 07/14/2023 | BDTX | Buy Now | Black Diamond Therapeutic | $4.37 | 151.72% | → $11 | Initiates | → Overweight | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 837.5% | $40 → $45 | Maintains | Overweight | Get Alert |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | — | — | $15 → $1.75 | Downgrade | Overweight → Neutral | Get Alert |
| 05/12/2023 | IBRX | Buy Now | ImmunityBio | $6.64 | -39.74% | $10 → $4 | Downgrade | Overweight → Neutral | Get Alert |
| 05/10/2023 | EXEL | Buy Now | Exelixis | $22.09 | 26.75% | → $28 | Assumes | → Overweight | Get Alert |
| 05/10/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.58 | -12.51% | → $46 | Upgrade | Neutral → Overweight | Get Alert |
| 05/05/2023 | SDGR | Buy Now | Schrodinger | $21.19 | 183.15% | → $60 | Assumes | → Overweight | Get Alert |
| 05/05/2023 | KROS | Buy Now | Keros Therapeutics | $41.68 | 163.92% | $120 → $110 | Maintains | Overweight | Get Alert |
| 05/03/2023 | IMGN | Buy Now | Immunogen | — | — | $6 → $16 | Upgrade | Neutral → Overweight | Get Alert |
| 04/28/2023 | GILD | Buy Now | Gilead Sciences | $67.72 | 55.05% | → $105 | Assumes | → Overweight | Get Alert |
| 04/03/2023 | IMAB | Buy Now | I-MAB | $1.60 | 1462.5% | $30 → $25 | Maintains | Overweight | Get Alert |
| 03/28/2023 | BMEA | Buy Now | Biomea Fusion | $4.80 | 733.33% | $16 → $40 | Maintains | Overweight | Get Alert |
| 01/27/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $7.32 | 91.26% | $11 → $14 | Upgrade | Neutral → Overweight | Get Alert |
| 01/09/2023 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 204.05% | $40 → $45 | Maintains | Overweight | Get Alert |
| 12/20/2022 | CPRX | Buy Now | Catalyst Pharmaceuticals | $15.45 | 29.45% | $18 → $20 | Maintains | Overweight | Get Alert |
| 12/12/2022 | ACRV | Buy Now | Acrivon Therapeutics | $7.08 | 253.11% | → $25 | Initiates | → Overweight | Get Alert |
| 12/07/2022 | ACHL | Buy Now | Achilles Therapeutics | $0.82 | 873.24% | $10 → $8 | Maintains | Overweight | Get Alert |
| 11/21/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $7.32 | 50.27% | $13 → $11 | Maintains | Neutral | Get Alert |
| 11/08/2022 | OYST | Buy Now | Oyster Point Pharma | — | — | $15 → $11 | Downgrade | Overweight → Neutral | Get Alert |
| 09/13/2022 | CRDF | Buy Now | Cardiff Oncology | $2.22 | 125.23% | $7 → $5 | Maintains | Overweight | Get Alert |
| 08/30/2022 | IMAB | Buy Now | I-MAB | $1.60 | 1775% | $35 → $30 | Maintains | Overweight | Get Alert |
| 08/11/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $90 → $70 | Maintains | Overweight | Get Alert |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $1.30 | 15.38% | $10 → $1.5 | Downgrade | Overweight → Neutral | Get Alert |
| 06/21/2022 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 170.27% | $35 → $40 | Maintains | Overweight | Get Alert |
| 06/02/2022 | RPTX | Buy Now | Repare Therapeutics | $3.21 | 834.58% | $25 → $30 | Maintains | Overweight | Get Alert |
| 05/27/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $7.32 | 77.6% | $20 → $13 | Maintains | Neutral | Get Alert |
| 05/12/2022 | EPIX | Buy Now | ESSA Pharma | $5.07 | 294.48% | $50 → $20 | Maintains | Overweight | Get Alert |
| 05/10/2022 | OCUL | Buy Now | Ocular Therapeutix | $6.66 | 140.24% | $20 → $16 | Maintains | Overweight | Get Alert |
| 05/05/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.33 | 12.78% | $25 → $1.5 | Downgrade | Overweight → Neutral | Get Alert |
| 03/14/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $270 → $150 | Maintains | Overweight | Get Alert |
| 03/10/2022 | SNSE | Buy Now | Sensei Biotherapeutics | $0.64 | 1474.56% | $12 → $10 | Maintains | Overweight | Get Alert |
| 03/02/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | $600 → $500 | Maintains | Overweight | Get Alert |
